- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00727467
A Randomised Controlled Trial (RCT) to Evaluate Use of an Individual Auditory Cueing Device's (IACD's) on Freezing and Gait in People With Parkinson's Disease (PD)
A Randomised Controlled Trial Evaluating the Effect of an Individual Auditory Cueing Device on Freezing and Gait Speed in People With Parkinson's Disease
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Anticipated)
Phase
- Phase 2
- Phase 1
Contacts and Locations
Study Contact
- Name: Emma K Stokes, PhD
- Phone Number: 00353 1 896 2127
- Email: estokes@tcd.ie
Study Contact Backup
- Name: Rose Galvin, BSc
- Phone Number: 003531 896 3613
- Email: rgalvin@tcd.ie
Study Locations
-
-
-
Cork, Ireland
- Cork University Hospital
-
Contact:
- Eilis Ni Charthaigh, BSc
- Phone Number: 353 21 454 6400
-
Principal Investigator:
- Eilis Ni Charthaigh, BSc
-
Dublin, Ireland
- Royal Hospital Donnybrook
-
Contact:
- Ola Wyszumirska, BS c
- Phone Number: 003531 4972844
-
Principal Investigator:
- Ola Wyszumirska
-
Dublin, Ireland
- Saint James's Hospital
-
Contact:
- Sheila McCarthy, BSc
- Phone Number: 0035314103000
-
Principal Investigator:
- Sheila McCarthy, BSc
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- PD
- medically stable
- willing to give informed consent
- freeze at least once per week (minimum score of 2 on item 3 of the FOGQ) for at least 2 seconds(minimum score of 1 on item 4 of FOGQ)
- MMSE Score greater than 24
Exclusion Criteria:
- attending physiotherapy at time of recruitment
- unwilling to give informed consent
- not medically stable
- cognitive impairment (MMSE score less than 24)
- acure co-morbidity that prevents mobility
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: A
On Days 1-8 of the trial, participants in Group A will be given the iPod with some music on the device to allow all participants to become familiar with the device i.e. turning device on and off, increasing and decreasing the volume. They will be instructed to use the device only when sitting at home, and that the device should not be turned on when walking or performing any mobility related or daily tasks. On Days 8-15, participants in Group A will be allocated to the 'intervention' phase. Each participant will be given an iPod containing an auditory cue in the form of a continuous metronome beat, individualised to the patient's walking frequency (less 10%).Participants will be instructed to listen to the cueing when they are performing any mobility related tasks. On Days 15-23, participants in Group A will be allocated to the 'control' phase. During this time period, participants will be provided with the iPod shuffle containing no music or metronome beat. |
Each participant will be given an iPod containing an auditory cue in the form of a continuous metronome beat, individualised to the patient's walking frequency (less 10%).Participants will be instructed to listen to the cueing when they are performing any mobility related tasks.
Other Names:
|
Active Comparator: B
On Days 1-8 of the trial, participants in Group B will be given the iPod with some music on the device to allow all participants to become familiar with the device. They will be instructed to use the device only when sitting at home, and that the device should not be turned on when walking or performing any mobility related or daily tasks. On Days 8-15, participants in Group B will be allocated to the 'control' phase. During this time period, participants will be provided with the iPod shuffle containing no music or metronome beat. On Days 15-23, participants in Group B will be allocated to the 'intervention phase'. Each participant will be given an iPod containing an auditory cue in the form of a continuous metronome beat, individualised to the patient's walking frequency (less 10%).Participants will be instructed to listen to the cueing when they are performing any mobility related tasks. |
Each participant will be given an iPod containing an auditory cue in the form of a continuous metronome beat, individualised to the patient's walking frequency (less 10%).Participants will be instructed to listen to the cueing when they are performing any mobility related tasks.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Freezing of Gait Questionnaire
Time Frame: Day 8, Day 15, Day 23 and 3 month follow up
|
Day 8, Day 15, Day 23 and 3 month follow up
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Timed Up and Go Test
Time Frame: Day 8, Day 15, Day 23 and three month follow-up
|
Day 8, Day 15, Day 23 and three month follow-up
|
Modified Falls Efficacy Scale
Time Frame: Day 8, Day 15, Day 23 and three month follow-up
|
Day 8, Day 15, Day 23 and three month follow-up
|
10 Metre Walk Test
Time Frame: Day 8, Day 15, Day 23 and three month follow-up
|
Day 8, Day 15, Day 23 and three month follow-up
|
Collaborators and Investigators
Investigators
- Principal Investigator: Emma K Stokes, PhD, University of Dublin, Trinity College
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 5-6-08
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Parkinson's Disease
-
Ohio State UniversityCompletedParkinson's Disease | Parkinson Disease | Idiopathic Parkinson Disease | Idiopathic Parkinson's Disease | Parkinson Disease, Idiopathic | Parkinson's Disease, IdiopathicUnited States
-
Assistance Publique - Hôpitaux de ParisFrance Parkinson AssociationUnknownHealthy Controls | Parkinson's Disease With LRRK2 Mutation | Parkinson's Disease Without LRRK2 MutationFrance
-
Merck Sharp & Dohme LLCCompletedParkinson Disease | Idiopathic Parkinson Disease | Idiopathic Parkinson's Disease
-
Universidade Federal de PernambucoCompletedParkinson's Disease.Brazil
-
University Hospital, GrenobleCompletedParkinson's Disease (Disorder)France
-
Neurocrine BiosciencesVoyager TherapeuticsCompletedBrain Diseases | Central Nervous System Diseases | Nervous System Diseases | Parkinson's Disease | Parkinsonian Disorders | Movement Disorders | Neurodegenerative Diseases | Idiopathic Parkinson's Disease | Basal Ganglia DiseaseUnited States
-
Shanghai East HospitalShanghai iCELL Biotechnology Co., Ltd, Shanghai, ChinaRecruitingIdiopathic Parkinson's DiseaseChina
-
Beijing Tiantan HospitalRecruitingPD - Parkinson's DiseaseChina
-
Kyowa Kirin Co., Ltd.Kyowa Hakko Kirin Pharma, Inc.CompletedIdiopathic Parkinson's DiseaseUnited States, Canada, Czechia, Germany, Israel, Italy, Poland, Serbia
-
Kyowa Kirin Co., Ltd.Kyowa Hakko Kirin Pharma, Inc.CompletedIdiopathic Parkinson's DiseaseUnited States, Canada, Czechia, Germany, Israel, Italy, Poland, Serbia
Clinical Trials on Auditory Cueing Device
-
Institute of Child HealthGateshead Health NHS Foundation TrustCompleted
-
Northumbria UniversityParkinson's Foundation; Northumbria Healthcare NHS Foundation TrustRecruiting
-
Northumbria Healthcare NHS Foundation TrustCompleted
-
Cliniques universitaires Saint-Luc- Université...CompletedParkinson Disease | Gait, UnsteadyBelgium
-
Austin HealthUnknown
-
Cairo UniversityCompletedHemiplegia, SpasticEgypt
-
Swiss Federal Institute of TechnologyRehaklinik Zihlschlacht AGRecruitingParkinson Disease | Freezing of GaitSwitzerland
-
National Institute of Neurological Disorders and...WithdrawnParkinson's Disease
-
National Institute of Mental Health (NIMH)Completed
-
University of North Carolina, Chapel HillCompletedParkinson DiseaseUnited States